SUMMARY Dorsal root ganglia from streptozotocin-diabetic rats and age-and weight-matched control animals were incubated with 4-amino 3H-butyric acid. A significant reduction in uptake was observed in the diabetic animals. The incorporation of 3H-leucine into protein was also significantly reduced but the results did not allow a conclusion as to whether this was a secondary or an independent effect. These findings are discussed in relation both to the abnormalities known to develop in diabetic rats, and to the causation of human diabetic neuropathy.
Since the first demonstration of reduced nerve conduction velocity in alloxan-diabetic rats by Eliasson,' numerous studies have been undertaken on alloxan or streptozotocin-induced diabetes in rats and rabbits, and more recently on spontaneous diabetes in animals, in an attempt to elucidate the cause of diabetic neuropathy in man.
A number of metabolic defects have been demonstrated in peripheral nerve in chemically-diabetic rats. Sorbitol is known to accumulate,2 related to augmentation of the sorbitol pathway consequent upon the hyperglycaemia. The concentration of myo-inositol is also known to be reduced.3 These observations have been separately implicated as having a possible causal relationship to the reduced nerve conduction velocity. Prevention of sorbitol accumulation with an aldose reductase inhibitor will improve conduction velocity,45 without change in the level of hyperglycaemia. Dietary supplementation with myo-inositol to restore nerve myo-inositol levels will also improve nerve conduction velocity,35 although this is difficult to demonstrate in mature animals that have ceased growing. 6 Additionally, it is known that Na+/K+ ATPase activity is reduced in diabetic nerve. ' Recent observations suggest that it may be possible to link these findings. Sorbitol Present address: *Department of Biological Sciences, Napier College, Edinburgh. tDepartment of Medicine, University of Patras Medical School, Patra, Greece. accumulation appears to be a factor responsible for the reduction in nerve myo-inositol concentration,8 in addition to competitive inhibition by glucose of Na-dependent myo-inositol uptake. 9 The changes in phospholipid-dependent membrane-associated ATPase activity provide a potential means of relating defective inositol phospholipid metabolism, reduced nerve conduction velocity, and impaired energy utilisation.'0'-2 It has been established that myo-inositol administration will prevent the reduction in Na+/K+ ATPase activity and that the reduced energy utilisation in endoneurial preparations of streptozotocin-diabetic rat nerve is restricted to the fraction that can be inhibited by ouabain and which is therefore attributable to Na+/K+ ATPase activity. Lastly, it has recently been found that the impaired Na+/K+ ATPase further interferes with Nadependent myo-inositol uptake, thus producing a self-reinforcing cycle of compromised myo-inositol and Na+/K+ ATPase function in diabetic peripheral nerve. '3 Another approach to the causation of diabetic neuropathy stems from the observation that nerve fibre diameter fails to show the normal increase during growth in streptozotocin-diabetic rats'4 and genetically diabetic mice.'5 This growth defect is prevented by insulin treatment. '6 It has been shown that the slow component a of axonal transport is impaired in streptozotocin-diabetic rats.'7 The hypothesis was therefore advanced that defective perikaryal synthesis of protein '8 or At biopsy under ether inhalation anaesthesia, laminectomy was performed and both first sacral dorsal root ganglia and the caudal two pairs of lumbar ganglia were removed under an operating microscope and transferred to the incubation medium. At each session, the ganglia from one diabetic and one control animal were processed. After excision, the three pairs of ganglia were placed in a petri dish containing 5 ml of Hank's solution (pH 7.2-7.4). Any extraneous pieces of spinal root, blood vessels, etc., were removed. The ganglia were transferred to a glass vial containing 5 ml of medium 199 (BDH Chemicals) with NaHCO3, and oxgyenated by blowing through a mixture of 95% 02 and 5% CO2 for 30 s.
For the observations on leucine uptake, 5 ,Ci of L-14, 5-3H] leucine (Amersham International) were then added to the sample tube, which was incubated in a shaking water bath at 37°C for 3 h. The subsequent method for extraction of the proteins follows that of Cavanagh and Chen20 with some modifications. Incubation was stopped by running in 5 ml of 10% (w/v) trichloracetic acid (TCA) and the tube centrifuged at 15 000 g for 15 min. All subsequent centrifugations were the same. The supernatant was discarded and 5 ml of cold (4°C) 10% TCA added. The ganglia were then macerated in a homogeniser and the tube centrifuged. The supernatant was discarded and the deposit suspended in 5 ml of cold TCA and again centrifuged. This was repeated twice. Following the third centrifugation, the deposit was washed in 5 ml of an ethanol/ether mixture (3:1 v/v) and centrifuged, the procedure being repeated consecutively with 5 ml chloroform/methanol (2/1 v/v) and with 5 ml ether. The deposit was resuspended in S ml of 5% TCA, heated in an oven at 90°C for 15 min and centrifuged, this procedure being repeated once. The deposit was finally washed in 5 ml of acetone and, after further centrifugation, resuspended in ether and allowed to dry. The residue was carefully scraped into a counting vial, using an ether wash if necessary, weighed, and 0-2 ml of distilled water added followed by 1 ml of NCS solubiliser. The vial was incubated in a water bath at 45°C until the tissue had dissolved and, after cooling, 4 ml of scintillation fluid (PPO/POPOP mixture) added. Counting was undertaken in a Packhard counter after the tube had been allowed to stand in the dark for about 11/2 h for the initial fluorescence to subside. Observations on the ganglia from four control animals showed that the uptake of 3H-leucine was linear after the 3 h incubation period (fig).
For the observations on the uptake of 4-amino butyric acid, 5 ,uCi of 4-amino-n-[2,3-3HI butyric acid (Amersham International) were added to the sample tubes containing the diabetic and control dorsal root ganglia, which were then incubated for 3 h at 37°C. Incubation was stopped by adding 5 ml of 10% trichloracetic acid and, after centrifugation, the ganglia were washed 3 times in isotonic saline 23 found a reduced incorporation of 1"Cleucine into the protein components of myelin from in vitro studies. Chihara2" reported that the incorporation of leucine into the retina of diabetic rabbits was reduced, as was the amount of radiolabelled protein transported along the optic nerve. Transport velocity was normal, suggesting that the reduced transport along the nerve was secondary to impaired protein synthesis in the ganglion cells. Sidenius and Jakobsen,25 during a study on axoplasmic transport, reported a 40% decrease in the incorporation of leucine when injected into the fifth lumbar ganglion of streptozotocin-diabetic rats, and the half-life of the labelled proteins in the ganglion did not differ from that of controls. Of particular interest in the present context is the observation of Bumham et a126 that insulin enhances the uptake of 3H-leucine and 3H-uridine by intact and dissociated fetal dorsal root ganglia.
Our present results have shown that the uptake of 3H-leucine into protein is diminished in the dorsal root ganglia of streptozotocin-diabetic rats. The inhibition by cycloheximide established that the 3H-leucine was incorporated into protein and that the results did not merely represent passive diffusion into the ganglia. Cycloheximide, at the concentration empolyed, has a marked inhibitory effect on protein synthesis in vitro27 The perikaryal volume of dorsal root ganglion cells has been found to be less in streptozotocin-diabetic rats as compared with controls.28 It is probable that, as for fibre size, this represents a failure of the normal increase during development and is thus unlikely to be a complicating factor in the present experiments in view of the maturity of the animals.
This study has shown that the uptake of the nonmetabolisable amino acid, 4-amino butyric acid, is depressed in the diabetic ganglia. Further studies will be required to establish whether the reduced incorporation of leucine into protein is secondary to the impaired amino acid uptake or whether it is an independent effect. It is of interest that observations on rat liver parenchyma cells have demonstrated that the uptake of 4-amino butyric acid is energy dependent and that the addition of insulin to the culture results in an increased influx of the amino acid.
Axonal structural proteins are synthesised in the neuronal perikaryon and transported down the axon in slow component a. This component carries tubulin and the neurofilament polypeptide triplet,29 and its velocity has been shown to be reduced in streptozotocin-diabetic rats. '9 Although Takenaka et a130 failed to detect any alteration in transport rate in L5 sensory fibres of diabetic rats, their results suggested that a reduced amount of neurofilament Amino acid uptake by dorsal root ganglia from streptozotocin-diabetic rats material was transported, implying reduced incorporation of the 35S-methionine which was injected into the ganglion. Sidenius and Jakobsen3' also found a reduction in the amount of label transported and showed that the reduction in transport velocity that they had detected could be corrected by insulin.
There is therefore good evidence for reduced perikaryal synthesis in neurons contributing fibres to the peripheral nerves, and a reduced delivery of structural proteins to the periphery of the axon. This is likely to explain the failure of peripheral nerve axons to increase in size normally in rats made diabetic before cessation of the growth period. If severe enough, it might lead to a distal axonal degeneration. It is so far uncertain whether the synthesis of cytosol proteins is also affected, but again a reduced delivery of enzymes to the periphery could lead to a distal axonopathy.
There 
